Breaking News: GNGBY latest news.

Over a month ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Recommendations	Getinge price target lowered to SEK 243 from SEK 250 at Morgan Stanley » 14:49 02/02/23 02/02 14:49 02/02/23 14:49 GNGBY Getinge $23.33 / +0.925 (+4.13%) Morgan Stanley analyst… Morgan Stanley analyst Robert Davies lowered the firm's price target on Getinge to SEK 243 from SEK 250 and keeps an Overweight rating on the shares. ShowHide Related Items >><< Street Research GNGBY Getinge $23.33 / +0.925 (+4.13%) 02/02/23 JPMorgan Getinge price target raised to SEK 208 from SEK 174 at JPMorgan 02/02/23 Pareto Getinge downgraded to Hold from Buy at Pareto 01/18/23 Morgan Stanley Getinge price target lowered to SEK 250 from SEK 274 at Morgan Stanley 01/03/23 JPMorgan Getinge downgraded to Underweight from Neutral at JPMorgan
Recommendations	Getinge price target raised to SEK 208 from SEK 174 at JPMorgan » 14:38 02/02/23 02/02 14:38 02/02/23 14:38 GNGBY Getinge $23.33 / +0.925 (+4.13%) JPMorgan analyst David… JPMorgan analyst David Adlington raised the firm's price target on Getinge to SEK 208 from SEK 174 and keeps an Underweight rating on the shares. ShowHide Related Items >><< Street Research GNGBY Getinge $23.33 / +0.925 (+4.13%) 02/02/23 Pareto Getinge downgraded to Hold from Buy at Pareto 01/18/23 Morgan Stanley Getinge price target lowered to SEK 250 from SEK 274 at Morgan Stanley 01/03/23 JPMorgan Getinge downgraded to Underweight from Neutral at JPMorgan 12/30/22 DNB Markets Getinge downgraded to Hold from Buy at DNB Markets
Downgrade	Getinge downgraded to Hold from Buy at Pareto » 05:00 02/02/23 02/02 05:00 02/02/23 05:00 GNGBY Getinge $23.33 / +0.925 (+4.13%) Pareto analyst Peter… Pareto analyst Peter Ostling downgraded Getinge to Hold from Buy with a SEK 255 price target. ShowHide Related Items >><< Street Research GNGBY Getinge $23.33 / +0.925 (+4.13%) 01/18/23 Morgan Stanley Getinge price target lowered to SEK 250 from SEK 274 at Morgan Stanley 01/03/23 JPMorgan Getinge downgraded to Underweight from Neutral at JPMorgan 12/30/22 DNB Markets Getinge downgraded to Hold from Buy at DNB Markets 10/20/22 JPMorgan Getinge price target lowered to SEK 285 from SEK 331 at JPMorgan
Recommendations	Getinge price target lowered to SEK 250 from SEK 274 at Morgan Stanley » 13:47 01/18/23 01/18 13:47 01/18/23 13:47 GNGBY Getinge $22.12 / +0.53 (+2.45%) Morgan Stanley analyst… Morgan Stanley analyst Robert Davies lowered the firm's price target on Getinge to SEK 250 from SEK 274 and keeps an Overweight rating on the shares. ShowHide Related Items >><< Street Research GNGBY Getinge $22.12 / +0.53 (+2.45%) 01/03/23 JPMorgan Getinge downgraded to Underweight from Neutral at JPMorgan 12/30/22 DNB Markets Getinge downgraded to Hold from Buy at DNB Markets 10/20/22 JPMorgan Getinge price target lowered to SEK 285 from SEK 331 at JPMorgan 10/20/22 Nordea Getinge upgraded to Buy from Hold at Nordea
Downgrade	Getinge downgraded to Underweight from Neutral at JPMorgan » 05:53 01/03/23 01/03 05:53 01/03/23 05:53 GNGBY Getinge $20.62 / -0.38 (-1.81%) , FMS Fresenius Medical $16.34 / +0.02 (+0.12%) JPMorgan analyst David… JPMorgan analyst David Adlington downgraded Getinge (GNGBY) to Underweight from Neutral with a price target of SEK 174, down from SEK 285. Consensus estimates for European medical technology "still looks too bullish to us on margins," Adlington tells investors in a research note. The analyst downgraded Getinge and placed Fresenius Medical Care (FMS) and the company on "negative catalyst watch." ShowHide Related Items >><< Company News Street Research FMS FMS Fresenius Medical $16.34 / +0.02 (+0.12%) 12/06/22 Fresenius Medical Care CEO Carla Kriwet departs amid 'strategic differences' 09/07/22 Fresenius Medical partners with National Kidney Foundation Malaysia 08/30/22 Fresenius Medical awarded five-year contract from U.S. Department of VA GNGBY FMS GNGBY Getinge $20.62 / -0.38 (-1.81%) 12/30/22 DNB Markets Getinge downgraded to Hold from Buy at DNB Markets 10/20/22 JPMorgan Getinge price target lowered to SEK 285 from SEK 331 at JPMorgan 10/20/22 Nordea Getinge upgraded to Buy from Hold at Nordea 10/18/22 Morgan Stanley Getinge initiated with an Overweight at Morgan Stanley FMS Fresenius Medical $16.34 / +0.02 (+0.12%) 01/03/23 Jefferies Jefferies double downgrades Fresenius Medical on 2023 headwinds 01/02/23 Jefferies Fresenius Medical downgraded to Underperform from Buy at Jefferies 11/09/22 Credit Suisse Fresenius Medical price target lowered to EUR 32 from EUR 37 at Credit Suisse 11/03/22 Deutsche Bank Fresenius Medical price target lowered to EUR 22 from EUR 24 at Deutsche Bank
Downgrade	Getinge downgraded to Hold from Buy at DNB Markets » 07:04 12/30/22 12/30 07:04 12/30/22 07:04 GNGBY Getinge $21.00 / +0.765 (+3.78%) DNB Markets analyst… DNB Markets analyst Patrik Ling downgraded Getinge to Hold from Buy with a SEK 240 price target. ShowHide Related Items >><< Street Research GNGBY Getinge $21.00 / +0.765 (+3.78%) 10/20/22 JPMorgan Getinge price target lowered to SEK 285 from SEK 331 at JPMorgan 10/20/22 Nordea Getinge upgraded to Buy from Hold at Nordea 10/18/22 Morgan Stanley Getinge initiated with an Overweight at Morgan Stanley 07/20/22 JPMorgan Getinge price target lowered to SEK 331 from SEK 344 at JPMorgan

Over a quarter ago
Recommendations	Getinge price target lowered to SEK 285 from SEK 331 at JPMorgan » 14:36 10/20/22 10/20 14:36 10/20/22 14:36 GNGBY Getinge $17.88 / -1.31 (-6.83%) JPMorgan analyst Craig… JPMorgan analyst Craig McDowell lowered the firm's price target on Getinge to SEK 285 from SEK 331 and keeps a Neutral rating on the shares. ShowHide Related Items >><< Street Research GNGBY Getinge $17.88 / -1.31 (-6.83%) 10/20/22 Nordea Getinge upgraded to Buy from Hold at Nordea 10/18/22 Morgan Stanley Getinge initiated with an Overweight at Morgan Stanley 07/20/22 JPMorgan Getinge price target lowered to SEK 331 from SEK 344 at JPMorgan 06/15/22 JPMorgan Getinge downgraded to Neutral from Overweight at JPMorgan
Upgrade	Getinge upgraded to Buy from Hold at Nordea » 05:26 10/20/22 10/20 05:26 10/20/22 05:26 GNGBY Getinge $17.88 / -1.31 (-6.83%) Nordea analyst Victor… Nordea analyst Victor Forssell upgraded Getinge to Buy from Hold with a SEK 260 price target. ShowHide Related Items >><< Street Research GNGBY Getinge $17.88 / -1.31 (-6.83%) 10/18/22 Morgan Stanley Getinge initiated with an Overweight at Morgan Stanley 07/20/22 JPMorgan Getinge price target lowered to SEK 331 from SEK 344 at JPMorgan 06/15/22 JPMorgan Getinge downgraded to Neutral from Overweight at JPMorgan 06/15/22 Nordea Getinge downgraded to Hold from Buy at Nordea
Initiation	Getinge initiated with an Overweight at Morgan Stanley » 07:16 10/18/22 10/18 07:16 10/18/22 07:16 GNGBY Getinge $18.14 / +0.48 (+2.72%) Morgan Stanley analyst… Morgan Stanley analyst Robert Davies initiated coverage of Getinge with an Overweight rating and SEK 274 price target. The EU Medtech group "looks attractive after the 2022 reset," said Davies as he initiated coverage of the group, citing its defensive characteristics and that fact that the stocks are "already an outlier among defensive industry groups." ShowHide Related Items >><< Street Research GNGBY Getinge $18.14 / +0.48 (+2.72%) 07/20/22 JPMorgan Getinge price target lowered to SEK 331 from SEK 344 at JPMorgan 06/15/22 JPMorgan Getinge downgraded to Neutral from Overweight at JPMorgan 06/15/22 Nordea Getinge downgraded to Hold from Buy at Nordea 06/13/22 Kepler Cheuvreux Getinge downgraded to Hold from Buy at Kepler Cheuvreux
Recommendations	Getinge price target lowered to SEK 331 from SEK 344 at JPMorgan » 15:21 07/20/22 07/20 15:21 07/20/22 15:21 GNGBY Getinge $22.38 / -0.365 (-1.61%) JPMorgan analyst Craig… JPMorgan analyst Craig McDowell lowered the firm's price target on Getinge to SEK 331 from SEK 344 and keeps a Neutral rating on the shares. ShowHide Related Items >><< Street Research GNGBY Getinge $22.38 / -0.365 (-1.61%) 06/15/22 JPMorgan Getinge downgraded to Neutral from Overweight at JPMorgan 06/15/22 Nordea Getinge downgraded to Hold from Buy at Nordea 06/13/22 Kepler Cheuvreux Getinge downgraded to Hold from Buy at Kepler Cheuvreux 04/27/22 JPMorgan Getinge price target lowered to SEK 425 from SEK 430 at JPMorgan

Get Full Fly Access